<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Doxifluridine, a <z:chebi fb="0" ids="50266">prodrug</z:chebi> of <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> (5-FU), was used as the initiator directly in ring-opening polymerization of ε-<z:chebi fb="0" ids="17915">caprolactone</z:chebi> to form hydrophobic doxifluridine-poly(ε-<z:chebi fb="0" ids="17915">caprolactone</z:chebi>) (doxifluridine-<z:chebi fb="43" ids="53200">PCL</z:chebi>) that was further grafted with hydrophilic <z:chebi fb="0" ids="16261">chitosan</z:chebi> to synthsize amphiphilic doxifluridine-<z:chebi fb="43" ids="53200">PCL</z:chebi>-<z:chebi fb="0" ids="16261">chitosan</z:chebi> <z:chebi fb="5" ids="53310">copolymer</z:chebi> </plain></SENT>
<SENT sid="1" pm="."><plain>This amphiphilic <z:chebi fb="5" ids="53310">copolymer</z:chebi> was self-assembled into micellar nanoparticles </plain></SENT>
<SENT sid="2" pm="."><plain>After HT-29 <z:hpo ids='HP_0003003'>colon cancer</z:hpo> cells were treated with the polymeric drug nanocarrier, <z:chebi fb="0" ids="50266">prodrug</z:chebi> doxifluridine was converted into <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> by endogenous <z:chebi fb="0" ids="17748">thymidine</z:chebi> phosphorylase (TP) and thereby resulting in cell <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Chemotherapy drug 7-ethyl-10-hydroxy-<z:chebi fb="0" ids="27656">camptothecin</z:chebi> (SN-38), an active water insoluble metabolite of irinoetcan <z:chebi fb="16" ids="36807">hydrochloride</z:chebi>, was further encapsulated in the hydrophobic core of the polymeric drug nanocarriers and treated with HT-29 cells </plain></SENT>
<SENT sid="4" pm="."><plain>The anticancer effectiveness of the polymeric drug nanocarriers was extensively enhanced by synergistic anticancer activity of slowly released cytotoxic drugs (i.e., 5-FU and SN-38) </plain></SENT>
<SENT sid="5" pm="."><plain>HT-29 cells transfected with TP-encoding plasmids were selected by antibiotic G418 to obtain HT-29/TP cells </plain></SENT>
<SENT sid="6" pm="."><plain>These cells overexpressed with TP enzyme were challenged with doxifluridine-<z:chebi fb="43" ids="53200">PCL</z:chebi>-<z:chebi fb="0" ids="16261">chitosan</z:chebi> polymeric <z:chebi fb="0" ids="50266">prodrug</z:chebi> micelles </plain></SENT>
<SENT sid="7" pm="."><plain>The viability of HT-29/TP cells were dropped significantly after 72-h treatment </plain></SENT>
</text></document>